Be Biopharma Stock

Q: How to sell Be Biopharma stock?

If you hold private company shares of Be Biopharma - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Be Biopharma stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

be.bioHealthcare / BioTech & PharmaFounded: 2020Funding to Date: $182.1MM

Be Biopharma (“Be Bio”) is pioneering Engineered B Cell Medicines (BeCM) to dramatically improve patients’ lives who are living with cancer, rare diseases and other serious conditions. The company's medicines address major hurdles of cell and gene therapies, and are durable, re-disable, and can be administered without toxic conditioning, thereby enabling healthcare sectors and patients to treat diseases like cancer, autoimmune conditions, and an enzyme deficiency. Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity. Be Bio was founded in October 2020 by Longwood Fund and B cell engineering pioneers David Rawlings, M.D., and Richard James, Ph.D. from Seattle Children’s Research Institute.

Buy or sell Be Biopharma stockLearn more about Be Biopharma IPO

OverviewFinancingsValuation

Enterprise Value

Access Be Biopharma’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Be Biopharma.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Be Biopharma investors also invested in these private companies

Atlas Venture

Whoop, DraftKings, Chroma Medicine, Sionna Therapeutics, Scorpion Therapeutics, Workhuman, Accent Therapeutics, DataXu, Obsidian Therapeutics, Be Biopharma

Ra Capital Management

X-energy, Element Biosciences, Mindtickle, BioAge, Freenome, Capstan Therapeutics, Synthego, Sionna Therapeutics, FogPharma, Bicara Therapeutics

Longwood Fund

Engrail Therapeutics, Tome Biosciences, Be Biopharma, Photys Therapeutics

Alta Partners

MBRace Therapeutics, Harbor Health, Transcarent, Be Biopharma

Takeda Ventures

Ensoma, Obsidian Therapeutics, Be Biopharma

Arch Venture Partners

Altos Labs, Resilience, Xaira Therapeutics, Insitro, Chroma Medicine, Generate Biomedicines, Moonwalk Biosciences, FogPharma, Seaport Therapeutics, Human Immunology Biosciences

Bristol Myers Squibb

Attralus, Capstan Therapeutics, Zenas BioPharma, BigHat Biosciences, Vedanta Biosciences, Cour Pharmaceuticals Development, Accent Therapeutics, Aktis Oncology, Cellares, Obsidian Therapeutics

Team

Management Team

Brad Hartman

Chief People Officer

Rick Morgan

Chief Scientific Officer

Lea Hachigian

Co-Founder & VP of Strategy

Joanne Smith-Farrell

Chief Executive Officer

Krishnan Viswanadhan

President & Chief Operating Officer

Board Members

Steven Gillis

Arch Venture Partners

Be Biopharma stock FAQs

Can you buy Be Biopharma stock?

As Be Biopharma is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Be Biopharma, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Be Biopharma stock?

To invest in a private company like Be Biopharma through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Be Biopharma stock?

Yes, you may be able to sell your Be Biopharma stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Be Biopharma stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Be Biopharma stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Be Biopharma a public company?

No, Be Biopharma is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Be Biopharma’s stock price?

Be Biopharma is a privately held company and therefore does not have a public stock price. However, you may access Be Biopharma’s private market stock price with Forge Data.

What is Be Biopharma’s stock ticker symbol?

Be Biopharma does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.